4.08
Esperion Therapeutics Inc (ESPR) 最新ニュース
Why The Narrative Around Esperion Therapeutics Is Shifting After Analyst Upgrades And Trial Results - Yahoo Finance
Esperion announces inducement grants under Nasdaq Listing Rule - marketscreener.com
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Esperion Grants Stock Options and RSUs to New Chief Commercial Officer and Employees - Quiver Quantitative
Esperion (NASDAQ: ESPR) awards 380K options, 435,536 RSUs in inducement grants - Stock Titan
Is Esperion Therapeutics Inc a good long term investmentMarket Sentiment Indicators & High Profit Market Tips - earlytimes.in
Esperion Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Two Seas Capital LP Raises Holdings in Esperion Therapeutics, Inc. $ESPR - MarketBeat
Will Esperion Therapeutics Inc. (0ET) stock enhance shareholder valueEarnings Overview Summary & Smart Money Movement Alerts - Newser
Esperion stock hits fair value target with 77% gain since April 2024 - Investing.com Australia
Esperion Therapeutics, Inc.Common Stock (Nasdaq:ESPR) Stock Quote - Markets Financial Content
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Esperion Therapeutics Inc. (0ET) stock a top dividend aristocrat candidateTrend Reversal & Stepwise Trade Execution Plans - Newser
Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week HighShould You Buy? - MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) Trading 6% HigherHere's What Happened - MarketBeat
Esperion a new overweight at Piper Sandler on CV franchise - MSN
Traders Purchase Large Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR) - MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) Coverage Initiated at Piper Sandler - MarketBeat
Esperion Therapeutics Stock Hits Near 1-Year High As Wall Street Sees Strong Risk-Reward Play On Demand For Cholesterol Drug - Stocktwits
Esperion Therapeutics: Soaring Momentum Observed - StocksToTrade
Piper Sandler Initiates Coverage of Esperion Therapeutics (ESPR) with Overweight Recommendation - Nasdaq
Piper Sandler initiates Esperion Therapeutics stock with Overweight rating By Investing.com - Investing.com South Africa
Esperion’s Strategic Moves: What It Means? - StocksToTrade
Esperion Therapeutics Shares Rise After Piper Sandler Initiates Coverage - marketscreener.com
Esperion Stock Grows Amid Promising Japanese Partnership and Q3 Earnings - timothysykes.com
Why Analysts Are Rewriting Esperion’s Story After New Pipeline Results and Global Partnerships - Yahoo Finance
Esperion gains after Piper Sandler initiates with 'overweight' rating - TradingView
United StatesGoodwin Advises Esperion On $75 Million Underwritten Public Offering - Mondaq
Piper Sandler initiates Esperion Therapeutics stock with Overweight rating - Investing.com
Esperion shares rise as Otsuka launches NEXLETOL in Japan By Investing.com - Investing.com Nigeria
Esperion Therapeutics Partner Rolls Out Nexletol Tablets in Japan to Treat Hypercholesterolemia - MarketScreener
Esperion stock rises after $90 million payment from Japan launch By Investing.com - Investing.com Australia
Esperion stock rises after $90 million payment from Japan launch - Investing.com
Is Esperion Therapeutics Inc. stock undervalued vs historical averages2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com
Esperion shares rise as Otsuka launches NEXLETOL in Japan - Investing.com India
Esperion partner Otsuka launches Nexletol in Japan - MarketScreener
Esperion Partners with Otsuka to Launch NEXLETOL in Japan, Secures $90 Million Payment - Quiver Quantitative
Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia - The Manila Times
Is Esperion Therapeutics Inc. stock a safe investment in uncertain markets2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Will Esperion Therapeutics Inc. stock recover faster than marketTreasury Yields & Daily Profit Focused Screening - newser.com
Why retail investors favor Esperion Therapeutics Inc. stock2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Esperion: HLS Therapeutics (TSX:HLS) Secures Health Canada Clearance for NILEMDO® - Kalkine Media
Why Esperion Therapeutics Inc. is moving todayMarket Movement Recap & Expert Verified Movement Alerts - newser.com
Multi asset correlation models including Esperion Therapeutics Inc.Portfolio Return Summary & Low Drawdown Momentum Ideas - newser.com
Will Esperion Therapeutics Inc. stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Esperion to Participate in Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Can Esperion Therapeutics Inc. stock double in next 5 yearsJuly 2025 Retail & Safe Swing Trade Setups - newser.com
大文字化:
|
ボリューム (24 時間):